Kredi Sermaye Değişiklik Tarih
AbbVie USD 62.48B 2.05B 2026-06
Agenus USD 153.98M 15.68M 2026-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.11B 358.58M 2026-09
Amgen USD 51.61B 250M 2026-09
Astellas Pharma JPY 270B 50B 2026-09
AstraZeneca USD 28.8B 2.79B 2026-09
Biogen USD 7.29B 1.7M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Bristol-Myers Squibb USD 41.85B 244M 2026-09
Eli Lilly USD 46.99B 872M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
GlaxoSmithKline GBP 21.7B 7.75B 2026-09
Incyte USD 28.42M 994K 2026-06
Ionis Pharmaceuticals USD 1.77B 140.62M 2026-09
J&J USD 35.8B 1.55B 2026-09
Kyowa Hakko Kirin JPY 24.12B 5.27B 2024-12
Merck USD 49.69B 1.39B 2026-09
Moderna USD 3.55B 2.95B 2026-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 38.38B 893M 2026-09
Novartis USD 36.7B 748M 2026-09
Pfizer USD 60B 498M 2026-09
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 14.65B 2.35B 2026-06
Sarepta Therapeutics USD 699.39M 148.23M 2026-09
Teva Pharmaceutical Industries USD 12.68B 588M 2026-09
Ultragenyx Pharmaceutical USD 1.13B 2M 2026-06
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09